Crispr Therapeutics Ag (CRSP)

$70.19 +2.45 (3.62%)
Market Cap 6.16B
Revenue (ttm) 37.31M
Net Income (ttm) -366.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -981.64%
Debt to Equity Ratio 0.00
Volume 2,476,700
Avg Vol 2,562,850
Day's Range N/A - N/A
Shares Out 90.95M
Stochastic %K 76%
Beta 1.84
Analysts Strong Sell
Price Target $80.62

Company Profile

CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. The company's CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs across a range of disease areas, including hemoglobinopathies, CAR...

Industry: Biotechnology
Sector: Healthcare
Phone: 41 41 561 32 77
Address:
Baarerstrasse 14, Zug, Switzerland
Boomhauer79
Boomhauer79 Oct. 7 at 12:30 AM
$CRSP what’s in the pipeline
1 · Reply
Scrapps64
Scrapps64 Oct. 7 at 12:05 AM
$CRSP Loving it
0 · Reply
ThorThunderGod
ThorThunderGod Oct. 6 at 11:46 PM
$CRSP IMHO $100 by EOY after that sky is the limit. They have so much in the pipeline and we have yet to have a major PR. When that happens I expect the stock to double!
0 · Reply
AxiomCurve
AxiomCurve Oct. 6 at 10:19 PM
$CRSP Mapping this stock with proprietary tools shows a double forthcoming Your chart may show something totally different I edit my own g nomes
0 · Reply
Coconutbeater
Coconutbeater Oct. 6 at 9:43 PM
$CRSP anyone thinking this will get cheaper is delusional. get in now n sell in 10 years. you’re welcome.
0 · Reply
StrongToro
StrongToro Oct. 6 at 9:11 PM
$NVTS PetroAI thesis: $DNA builds life-data, $CRSP edits it in real time, Tesla/Neuralink bridge bio-energy, $NVTS powers the grid, $SOC secures it, and $ASTS carries it across space. In this model, life + AI don’t just adapt to energy—they reprogram it.
1 · Reply
Scottydoesntreallyknow
Scottydoesntreallyknow Oct. 6 at 8:45 PM
$DNA $CRSP $TSLA $NVTS $ASTS 🤔 https://x.com/grok/status/1975289621400723869?s=46
1 · Reply
burbs88
burbs88 Oct. 6 at 8:41 PM
$CRSP Still here. Still very bullish long term, moderately bullish short term. That is all.
0 · Reply
RideTheBu77
RideTheBu77 Oct. 6 at 8:04 PM
$CRSP Welcome to the 70's ya'll ...
0 · Reply
handmedown1
handmedown1 Oct. 6 at 7:14 PM
$CRSP it is clear. If the data is positive. This could be 500$
1 · Reply
Latest News on CRSP
CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

Oct 1, 2025, 8:00 AM EDT - 5 days ago

CRISPR Therapeutics to Present Preclinical Data on Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTase Gene Editing Technology at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress

Crispr Therapeutics: Why Stock Fell On Q2 Earnings, And Why We're Now Back On Track

Sep 17, 2025, 4:09 PM EDT - 19 days ago

Crispr Therapeutics: Why Stock Fell On Q2 Earnings, And Why We're Now Back On Track

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

Sep 9, 2025, 4:00 PM EDT - 27 days ago

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade.

Sep 9, 2025, 2:22 PM EDT - 27 days ago

Biotech Sector Shows No Signs of Slowing. 3 Stocks That Make the Grade.

INCY XBI XLV

CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 11:38 AM EDT - 27 days ago

CRISPR Therapeutics AG (CRSP) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference Transcript

Sep 9, 2025, 6:53 AM EDT - 27 days ago

CRISPR Therapeutics AG (CRSP) Presents at H.C. Wainwright 27th Annual Global Investment Conference Transcript

Crispr Therapeutics: A Winning Lottery Ticket Doesn't Replace Grand Strategy

Sep 2, 2025, 8:55 AM EDT - 4 weeks ago

Crispr Therapeutics: A Winning Lottery Ticket Doesn't Replace Grand Strategy

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Sep 2, 2025, 8:00 AM EDT - 4 weeks ago

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

Crispr Therapeutics: A Speculative Buy With Promising Potential Ahead

Aug 27, 2025, 6:21 AM EDT - 5 weeks ago

Crispr Therapeutics: A Speculative Buy With Promising Potential Ahead

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

Aug 14, 2025, 1:02 PM EDT - 7 weeks ago

Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next Decade

AMD ARKF ARKG ARKK ARKQ ARKW ARKX

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

Aug 14, 2025, 7:27 AM EDT - 7 weeks ago

Upgrading Crispr Therapeutics To Hold Ahead Of A Catalyst-Rich 2H 2025

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Aug 4, 2025, 4:15 PM EDT - 2 months ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

Jul 23, 2025, 11:03 AM EDT - 2 months ago

Crispr Therapeutics: Shares Are Soaring - This Could Be The Start Of Something Big

The Big 3: ASML, GOOGL, CRSP

Jul 15, 2025, 12:01 PM EDT - 2 months ago

The Big 3: ASML, GOOGL, CRSP

ASML GOOG GOOGL

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

Jul 14, 2025, 8:00 AM EDT - 3 months ago

Crispr Therapeutics' Bright Future Is Coming Into Focus (Rating Upgrade)

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

Jun 26, 2025, 7:00 AM EDT - 3 months ago

CRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular Pipeline

The Big 3: CRSP, OKLO, GME

Jun 23, 2025, 12:01 PM EDT - 3 months ago

The Big 3: CRSP, OKLO, GME

OKLO GME

Crispr Therapeutics: Betting On A One-Shot Future

Jun 13, 2025, 6:27 PM EDT - 4 months ago

Crispr Therapeutics: Betting On A One-Shot Future

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Jun 9, 2025, 5:50 PM EDT - 4 months ago

CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

Jun 3, 2025, 4:07 PM EDT - 4 months ago

CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

May 9, 2025, 7:14 AM EDT - 5 months ago

Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still Shines

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

May 8, 2025, 8:36 AM EDT - 5 months ago

CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

May 7, 2025, 4:03 PM EDT - 5 months ago

Crispr Therapeutics Q1 Earnings Analysis: Ignore The Gloom, Stay The Course

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

May 7, 2025, 2:17 PM EDT - 5 months ago

CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: Analyst

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

May 7, 2025, 8:39 AM EDT - 5 months ago

These Analysts Slash Their Forecasts On CRISPR Therapeutics Following Q1 Results

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

May 6, 2025, 4:01 PM EDT - 5 months ago

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

May 5, 2025, 4:44 AM EDT - 5 months ago

CRISPR Therapeutics And Intellia Therapeutics: Balancing Market Uncertainty Against Pipeline Catalysts

NTLA

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

Apr 8, 2025, 3:29 PM EDT - 6 months ago

CRISPR Therapeutics AG (CRSP) Annual Needham Virtual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 8:00 AM EDT - 6 months ago

CRISPR Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

CRISPR Therapeutics Announces Transition of Chief Operating Officer

Mar 26, 2025, 4:01 PM EDT - 6 months ago

CRISPR Therapeutics Announces Transition of Chief Operating Officer

CRISPR Therapeutics Set To Reach Previous Heights

Mar 25, 2025, 11:03 AM EDT - 6 months ago

CRISPR Therapeutics Set To Reach Previous Heights

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 3:28 PM EST - 7 months ago

CRISPR Therapeutics AG (CRSP) TD Cowen 45th Annual Healthcare Conference (Transcript)

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Feb 26, 2025, 8:00 AM EST - 7 months ago

CRISPR Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

Feb 13, 2025, 11:06 AM EST - 8 months ago

Crispr Therapeutics Q4 Earnings Review: Ignore The Lack Of Revenues, Buy The Future

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Feb 11, 2025, 4:01 PM EST - 8 months ago

CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Feb 5, 2025, 4:16 PM EST - 8 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim SMID Cap Biotech Conference (Transcript)

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Feb 5, 2025, 3:48 PM EST - 8 months ago

Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

Jan 15, 2025, 7:20 PM EST - 9 months ago

CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

Jan 14, 2025, 7:39 PM EST - 9 months ago

CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript)

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 8:30 AM EST - 9 months ago

CRISPR Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

Dec 29, 2024, 12:56 PM EST - 10 months ago

Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

Dec 9, 2024, 12:00 PM EST - 10 months ago

CRISPR Therapeutics Presents Data at the 2024 American Society of Hematology (ASH) Annual Meeting

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

Nov 20, 2024, 9:28 PM EST - 11 months ago

CRISPR Therapeutics AG (CRSP) Jefferies London Healthcare Conference (Transcript)

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

Nov 15, 2024, 11:37 AM EST - 11 months ago

CRISPR Therapeutics AG (CRSP) Guggenheim Inaugural Healthcare Innovation Conference (Transcript)

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Nov 14, 2024, 8:30 AM EST - 11 months ago

CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

Nov 11, 2024, 12:54 PM EST - 11 months ago

Crispr Therapeutics Q3 Earnings: No Casgevy Revenue, But Plenty Of Optimism

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Nov 5, 2024, 9:01 AM EST - 11 months ago

CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Crispr Therapeutics: Poised For A Major Turnaround

Oct 28, 2024, 6:36 AM EDT - 1 year ago

Crispr Therapeutics: Poised For A Major Turnaround

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

Oct 6, 2024, 2:00 PM EDT - 1 year ago

Buying Opportunities In Biotech And Pharma With Bhavneesh Sharma

AMGN BIIB BLUE BMY EDIT EXAS NTLA

Crispr Therapeutics: Prepare To Be Bored

Sep 18, 2024, 9:11 AM EDT - 1 year ago

Crispr Therapeutics: Prepare To Be Bored

Boomhauer79
Boomhauer79 Oct. 7 at 12:30 AM
$CRSP what’s in the pipeline
1 · Reply
Scrapps64
Scrapps64 Oct. 7 at 12:05 AM
$CRSP Loving it
0 · Reply
ThorThunderGod
ThorThunderGod Oct. 6 at 11:46 PM
$CRSP IMHO $100 by EOY after that sky is the limit. They have so much in the pipeline and we have yet to have a major PR. When that happens I expect the stock to double!
0 · Reply
AxiomCurve
AxiomCurve Oct. 6 at 10:19 PM
$CRSP Mapping this stock with proprietary tools shows a double forthcoming Your chart may show something totally different I edit my own g nomes
0 · Reply
Coconutbeater
Coconutbeater Oct. 6 at 9:43 PM
$CRSP anyone thinking this will get cheaper is delusional. get in now n sell in 10 years. you’re welcome.
0 · Reply
StrongToro
StrongToro Oct. 6 at 9:11 PM
$NVTS PetroAI thesis: $DNA builds life-data, $CRSP edits it in real time, Tesla/Neuralink bridge bio-energy, $NVTS powers the grid, $SOC secures it, and $ASTS carries it across space. In this model, life + AI don’t just adapt to energy—they reprogram it.
1 · Reply
Scottydoesntreallyknow
Scottydoesntreallyknow Oct. 6 at 8:45 PM
$DNA $CRSP $TSLA $NVTS $ASTS 🤔 https://x.com/grok/status/1975289621400723869?s=46
1 · Reply
burbs88
burbs88 Oct. 6 at 8:41 PM
$CRSP Still here. Still very bullish long term, moderately bullish short term. That is all.
0 · Reply
RideTheBu77
RideTheBu77 Oct. 6 at 8:04 PM
$CRSP Welcome to the 70's ya'll ...
0 · Reply
handmedown1
handmedown1 Oct. 6 at 7:14 PM
$CRSP it is clear. If the data is positive. This could be 500$
1 · Reply
603stockgoat
603stockgoat Oct. 6 at 6:43 PM
$CRSP KNOW WHAT YOU OWN
0 · Reply
averageshmo
averageshmo Oct. 6 at 6:31 PM
$DAWN bought in at $7.50. Going along with my other biotech stocks $MRNA $CRSP $PRME $RXRX
1 · Reply
MikiTrader
MikiTrader Oct. 6 at 5:41 PM
$CRSP There’s still a long way to go. We’ve only just opened the door. The imbalance in development between research fields has been weakened, and it is time for CRSP to take flight again.
0 · Reply
QuietTrader
QuietTrader Oct. 6 at 5:33 PM
$CRSP Love this stock… Heading to $100 and beyond. CTX310 will be a game changer.
0 · Reply
Tejj
Tejj Oct. 6 at 5:20 PM
$CRSP 85 - 90 by xmas would be a treat.
0 · Reply
skcots_13
skcots_13 Oct. 6 at 5:07 PM
$CRSP CRSP TREATS! Snap, Crackle and Pop!
0 · Reply
HodlTurtle
HodlTurtle Oct. 6 at 5:05 PM
$CRSP shorts starting to cover 👌🏼
0 · Reply
StB55
StB55 Oct. 6 at 4:27 PM
$CRSP I have never experienced a short squeeze before. Please crsp could you make my dream come true...
0 · Reply
Tobi1981
Tobi1981 Oct. 6 at 4:27 PM
$CRSP any pricetags till EOY?
1 · Reply
RealWASP
RealWASP Oct. 6 at 3:58 PM
$CRSP looks like all the shorties have been exhausted at opening... keep squeezing.
0 · Reply
KevinDaBull
KevinDaBull Oct. 6 at 3:54 PM
$CRSP hoping there’s a dip with the conference, then off to the races as we get ready for CART sometime this year $NTLA could go with it for now
0 · Reply
Clargy
Clargy Oct. 6 at 3:50 PM
$CRSP $ARKG This move is just getting started, IMO.
1 · Reply